The Whole Toolkit Tested in Carotid Artery Stenting

This study sought to randomly compare the double-layer Roadsaver stent (Terumo) with the single-layer Carotid Wallstent device (Boston) in association with either distal filter-like embolic protection device FilterWire (Boston) or proximal protection device Mo.Ma (Medtronic) in patients with lipid-rich carotid plaques.

Por primera vez un estudio confirma que las pantallas de protección plomadas resguardan de la radiación a todo el personal de la sala de cateterismos

This is a very interesting work because there are no head-to-head simultaneous comparisons between these stent types and these brain protection systems: we only had physiopathological speculation.

A total of 104 consecutive patients were randomized to carotid artery stenting with FilterWire + Roadsaver stent (group 1, n = 27), FilterWire + Wallstent (group 2, n = 25), Mo.Ma + Roadsaver stent (group 3, n = 27), or Mo.Ma + Wallstent (group 4, n = 25).

The primary endpoint was the number of microembolic signals on transcranial Doppler in each procedural step: target vessel access; lesion wiring; pre-dilation; stent crossing; stent deployment; post-dilation, and device retrieval.


Read also: Crest-2 Registry: Carotid PCI Presents Low Rates of Death and Stroke.


The Mo.Ma was significantly superior to the FilterWire device in the reduction of microembolic signals (p < 0.0001) during lesion crossing, stent crossing, stent deployment, and post-dilation.

The Roadsaver was significantly superior to the Wallstent device (p = 0.016) during stent deployment and device retrieval. It also reduced the number of spontaneous microembolic signals (29% of patients).

The combination of proximal protection device Mo.Ma and double-layer stent Roadsaver was superior (p = 0.043) to all other combinations.


Read also: New Device for More Protection in Carotid Artery Stenting.


These were the differences found regarding microembolic signals on transcranial Doppler, but there were no clinical differences.

After stenting, peak systolic velocity decreased in all patients. At 6 months, only one patient experienced restenosis.

Conclusion

In patients with high-risk, lipid-rich carotid plaque, angioplasty combining proximal protection device Mo.Ma and double-layer stent Roadsaver resulted in the lowest number of microembolic signals on transcranial Doppler.

Original title: Carotid Wallstent Versus Roadsaver Stent and Distal Versus Proximal Protection on Cerebral Microembolization During Carotid Artery Stenting.

Reference: Piero Montorsi et al. J Am Coll Cardiol Intv 2020;13:403–14.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...